ESCRS - Optovue Supplement: OCT Angiography: The Newest Frontier for the Revolutionary Technology

Optovue Supplement: OCT Angiography: The Newest Frontier for the Revolutionary Technology

Optovue Supplement: OCT Angiography: The Newest Frontier for the Revolutionary Technology

The AngioVue Difference

Optovue has developed a new way of visualizing vessels that allows clinicians to identify retinal circulation using the intrinsic motion of the bloodcells in the vessel with non-invasive microvascular enhanced imaging. These devices use optical coherence tomography-angiography (OCT-A), and are by far the most advanced imaging products to date.

The AngioVue Imaging System is not like traditional OCT. It acquires function rather than structural information. This system is also very different from traditional angiography such as fluorescein angiography or ICAG since it does not require contrast dye injection that can be difficult to accomplish on some patients. Download Supplement - click here

Latest Articles
Diamonds in the Rough

The push for inclusivity in ophthalmology.

Read more...

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

Read more...

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Read more...

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Read more...

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Read more...

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Read more...

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Read more...

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Read more...

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Read more...

Supplement: Maximizing Visual Quality in Refractive Surgery Through Enhanced Precision and Safety

Read more...